Ep 08: KEYNOTE 716
Summary In this episode of Melanoma Matters, James Larkin and Sapna Patel discuss the Keynote 716 trial, focusing on the treatment of stage 2 melanoma. They explore the implications of adjuvant therap...
14 Loka 202431min
Ep 07: KEYNOTE 054
Summary James is injured! Hear about his favorite style of exercise (strength v cardio), and his no excuses attitude towards aches, pains, and niggles. In this episode, Sapna and James discuss the Ke...
14 Loka 202420min
Ep 06: CheckMate 238
Summary In this conversation, Sapna Patel and James Larkin discuss the Checkmate 238 landmark study on adjuvant therapy for melanoma. They touch on various topics, including food choices, pets, and th...
14 Loka 202418min
Ep 05: SWOG S1404
In this conversation, James Larkin and Sapna Patel discuss the SWOG adjuvant study in melanoma. They cover topics such as the study design, the use of adjuvant anti-PD-1 therapy, the comparison with i...
14 Loka 202425min
Ep 04: EORTC 18071
In this conversation, Sapna Patel and James Larkin discuss the EORTC 18071 study, which compared adjuvant ipilimumab to placebo in patients with stage III melanoma. They explore the use of adjuvant in...
14 Loka 202417min
Ep 03: CheckMate-204
Summary In this conversation, James Larkin and Sapna Patel discuss the findings of the Checkmate 204 study, which looked at the treatment of brain metastases from melanoma using nivolumab and ipilimum...
14 Loka 202427min
Ep 02: RELATIVITY-047
Summary In this episode of Melanoma Matters, James Larkin and Sapna Patel discuss the RELATIVITY 047 trial, which evaluated the combination of nivolumab and relatlimab in frontline metastatic melanoma...
14 Loka 202426min
Ep 01: CheckMate-067
In this inaugural episode of Melanoma Matters, hear our what, why, and thank yous. Thank you (luv-u) to our producer big sister (general) Kippy, to David Gedge and The Wedding Present for use of their...
14 Loka 202424min
